U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206986
Company: ALVOGEN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
HYDROCODONE BITARTRATE HYDROCODONE BITARTRATE 10MG CAPSULE, EXTENDED RELEASE;ORAL Prescription None No Yes
HYDROCODONE BITARTRATE HYDROCODONE BITARTRATE 15MG CAPSULE, EXTENDED RELEASE;ORAL Prescription None No No
HYDROCODONE BITARTRATE HYDROCODONE BITARTRATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription None No No
HYDROCODONE BITARTRATE HYDROCODONE BITARTRATE 30MG CAPSULE, EXTENDED RELEASE;ORAL Prescription None No No
HYDROCODONE BITARTRATE HYDROCODONE BITARTRATE 40MG CAPSULE, EXTENDED RELEASE;ORAL Prescription None No No
HYDROCODONE BITARTRATE HYDROCODONE BITARTRATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription None No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/21/2020 ORIG-1 Approval STANDARD Letter (PDF)

Label is not available on this site.

 https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/206986Orig1s000ltr.pdf
Back to Top